These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 8582783)

  • 1. Benefit of oral zinc supplementation as an adjunct to zidovudine (AZT) therapy against opportunistic infections in AIDS.
    Mocchegiani E; Veccia S; Ancarani F; Scalise G; Fabris N
    Int J Immunopharmacol; 1995 Sep; 17(9):719-27. PubMed ID: 8582783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic application of zinc in human immunodeficiency virus against opportunistic infections.
    Mocchegiani E; Muzzioli M
    J Nutr; 2000 May; 130(5S Suppl):1424S-31S. PubMed ID: 10801955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AIDS therapy with two, three or four agent combinations, applied in short sequences, differing from each other by drug rotation. I. First of two parts: a phase I trial equivalent, concerning five virostatics: AZT, ddI, ddC, acriflavine and an ellipticine analogue.
    Mathé G; Pontiggia P; Orbach-Arbouys S; Triana K; Ambetima N; Morette C; Hallard M; Blanquet D
    Biomed Pharmacother; 1996; 50(5):220-7. PubMed ID: 8949403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Zidovudine and lamivudine: results of phase III studies.
    Staszewski S
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995; 10 Suppl 1():S57. PubMed ID: 8595510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial.
    Fischl MA; Richman DD; Grieco MH; Gottlieb MS; Volberding PA; Laskin OL; Leedom JM; Groopman JE; Mildvan D; Schooley RT
    N Engl J Med; 1987 Jul; 317(4):185-91. PubMed ID: 3299089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of the low zinc bioavailability on cellular immune effectiveness in cystic fibrosis.
    Mocchegiani E; Provinciali M; Di Stefano G; Nobilini A; Caramia G; Santarelli L; Tibaldi A; Fabris N
    Clin Immunol Immunopathol; 1995 Jun; 75(3):214-24. PubMed ID: 7539347
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytomegalovirus retinitis under combination therapy with zidovudine and dideoxycytidine in advanced human immunodeficiency virus infection.
    Kaulen P; Pham DT; Baranowski E; Wollensak J
    Ger J Ophthalmol; 1993 Nov; 2(6):412-5. PubMed ID: 8312826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Outdated yet out-of-reach: AIDS society treatment guidelines at the International Conference.
    Torres G
    GMHC Treat Issues; 1996 Sep; 10(9):7, 10-1. PubMed ID: 11363842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Report on a 3-year follow-up zidovudine (AZT) treatment in a group of HIV-positive patients with congenital clotting disorders.
    Sartori MT; Mares M; Zerbinati P; Stocco D; Girolami A
    Haematologia (Budap); 1994; 26(1):17-27. PubMed ID: 7959371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of selenium and zinc on CD4(+) count and opportunistic infections in HIV/AIDS patients: a randomized double blind trial.
    Hadadi A; Ostovar A; Edalat Noor B; Rasoolinejad M; Haji Abdolbaghi M; Yousefi S; Khalili H; Manshoori G; Khashayar P; Alipour Z; Safari N
    Acta Clin Belg; 2020 Jun; 75(3):170-176. PubMed ID: 30888253
    [No Abstract]   [Full Text] [Related]  

  • 11. Oral zinc supplementation in Down's syndrome: restoration of thymic endocrine activity and of some immune defects.
    Franceschi C; Chiricolo M; Licastro F; Zannotti M; Masi M; Mocchegiani E; Fabris N
    J Ment Defic Res; 1988 Jun; 32 ( Pt 3)():169-81. PubMed ID: 2971113
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A controlled trial of intravenous immune globulin for the prevention of serious bacterial infections in children receiving zidovudine for advanced human immunodeficiency virus infection. Pediatric AIDS Clinical Trials Group.
    Spector SA; Gelber RD; McGrath N; Wara D; Barzilai A; Abrams E; Bryson YJ; Dankner WM; Livingston RA; Connor EM
    N Engl J Med; 1994 Nov; 331(18):1181-7. PubMed ID: 7935655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of zidovudine in 365 consecutive patients with AIDS or AIDS-related complex.
    Dournon E; Matheron S; Rozenbaum W; Gharakhanian S; Michon C; Girard PM; Perronne C; Salmon D; De Truchis P; Leport C
    Lancet; 1988 Dec; 2(8623):1297-302. PubMed ID: 2904016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HIV infection and AIDS.
    Lloyd A
    P N G Med J; 1996 Sep; 39(3):174-80. PubMed ID: 9795558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The safety and efficacy of zidovudine (AZT) in the treatment of subjects with mildly symptomatic human immunodeficiency virus type 1 (HIV) infection. A double-blind, placebo-controlled trial. The AIDS Clinical Trials Group.
    Fischl MA; Richman DD; Hansen N; Collier AC; Carey JT; Para MF; Hardy WD; Dolin R; Powderly WG; Allan JD
    Ann Intern Med; 1990 May; 112(10):727-37. PubMed ID: 1970466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of zidovudine treatment in homosexual men with AIDS-related complex: factors influencing development of AIDS, survival and drug intolerance. Australian Zidovudine Study Group.
    Swanson CE; Tindall B; Cooper DA
    AIDS; 1994 May; 8(5):625-34. PubMed ID: 8060543
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence and natural history of Mycobacterium avium-complex infections in patients with advanced human immunodeficiency virus disease treated with zidovudine. The Zidovudine Epidemiology Study Group.
    Chaisson RE; Moore RD; Richman DD; Keruly J; Creagh T
    Am Rev Respir Dis; 1992 Aug; 146(2):285-9. PubMed ID: 1362634
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies of zidovudine in combination with didanosine and zalcitabine.
    Jablonowski H
    J Acquir Immune Defic Syndr Hum Retrovirol; 1995; 10 Suppl 1():S52-6. PubMed ID: 8595509
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversibility of the thymic involution and of age-related peripheral immune dysfunctions by zinc supplementation in old mice.
    Mocchegiani E; Santarelli L; Muzzioli M; Fabris N
    Int J Immunopharmacol; 1995 Sep; 17(9):703-18. PubMed ID: 8582782
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The efficacy and safety of zidovudine alone or as cotherapy with acyclovir for the treatment of patients with AIDS and AIDS-related complex: a double-blind randomized trial. European-Australian Collaborative Group.
    Cooper DA; Pehrson PO; Pedersen C; Moroni M; Oksenhendler E; Rozenbaum W; Clumeck N; Faber V; Stille W; Hirschel B
    AIDS; 1993 Feb; 7(2):197-207. PubMed ID: 8096703
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.